A down-regulation of PP2A in AD brain was found by our and other groups [9], [11], [12], [13], [14], suggesting that this decrease may be partially responsible for the abnormal hyperphosphorylation of tau in AD. This evidence concerns the gene MAPT and Alzheimer disease.